Picard Medical, Inc.(PMI)
$7.24+0.01 (+0.14%)
PMI
Picard Medical, Inc. financials statements
$7.24
At close:+0.01 (+0.14%)
Want to see PMI full AI Analyst Report?
Picard Medical, Inc. (PMI) Ratios
91 Followers
Picard Medical, Inc. Ratios
PMI's free cash flow for Q2 2026 was $-1.35M. For the 2026 fiscal year, PMI's free cash flow was increased by $0.00 and operating cash flow was $-1.35M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 1.11 | 0.28 | 0.95 | 4.04 |
| Quick Ratio | 0.72 | 0.05 | 0.20 | 1.60 |
| Cash Ratio | 0.40 | 0.00 | 0.03 | 0.05 |
| Solvency Ratio | -1.41 | -0.57 | -1.00 | -2.61 |
| Operating Cash Flow Ratio | -0.84 | -0.34 | -1.15 | -3.58 |
| Short-Term Operating Cash Flow Coverage | -2.43 | -0.59 | -2.62 | -17.30 |
| Net Current Asset Value | $ 1.97M | $ -26.05M | $ -6.17M | $ 8.05M |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.31 | 1.73 | 0.83 | 0.13 |
| Debt-to-Equity Ratio | 1.84 | -0.88 | -2.65 | 0.17 |
| Debt-to-Capital Ratio | 0.65 | -7.45 | 1.61 | 0.15 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 5.87 | 0.00 |
| Financial Leverage Ratio | 5.95 | -0.51 | -3.20 | 1.36 |
| Debt Service Coverage Ratio | -4.11 | -0.76 | -3.54 | -16.99 |
| Interest Coverage Ratio | 0.00 | -4.47 | -110.73 | -2213.40 |
| Debt to Market Cap | 0.05 | 0.06 | 0.03 | 0.00 |
| Interest Debt Per Share | 4.73 | 0.33 | 0.13 | 0.03 |
| Net Debt to EBITDA | 0.02 | -1.19 | -0.62 | -0.17 |
| Profitability Margins | ||||
| Gross Profit Margin | 4.05% | -2.55% | -45.83% | -121.27% |
| EBIT Margin | -546.56% | -410.00% | -305.99% | -271.14% |
| EBITDA Margin | -536.19% | -397.63% | -294.39% | -257.89% |
| Operating Profit Margin | -259.11% | -312.28% | -307.40% | -269.07% |
| Pretax Profit Margin | -546.56% | -479.85% | -308.76% | -271.26% |
| Net Profit Margin | -546.56% | -479.50% | -308.72% | -271.53% |
| Continuous Operations Profit Margin | -546.56% | -479.50% | -308.72% | -271.53% |
| Net Income Per EBT | 100.00% | 99.93% | 99.99% | 100.10% |
| EBT Per EBIT | 210.94% | 153.66% | 100.45% | 100.81% |
| Return on Assets (ROA) | -119.74% | -173.92% | -136.88% | -72.33% |
| Return on Equity (ROE) | -712.59% | 88.70% | 438.32% | -98.23% |
| Return on Capital Employed (ROCE) | -332.21% | 59.06% | -717.02% | -88.96% |
| Return on Invested Capital (ROIC) | -118.91% | 487.80% | -237.40% | -83.04% |
| Return on Tangible Assets | -126.03% | -193.25% | -154.53% | -79.46% |
| Earnings Yield | -20.93% | -6.37% | -4.71% | -3.38% |
| Efficiency Ratios | ||||
| Receivables Turnover | 6.53 | 7.03 | 6.81 | 1.13 |
| Payables Turnover | 2.28 | 0.85 | 2.39 | 6.54 |
| Inventory Turnover | 0.65 | 0.55 | 1.07 | 1.24 |
| Fixed Asset Turnover | 7.08 | 3.98 | 3.84 | 2.13 |
| Asset Turnover | 0.22 | 0.36 | 0.44 | 0.27 |
| Working Capital Turnover Ratio | -0.42 | -0.34 | 1.16 | 0.00 |
| Cash Conversion Cycle | 458.20 | 280.70 | 242.73 | 561.19 |
| Days of Sales Outstanding | 55.93 | 51.95 | 53.63 | 323.20 |
| Days of Inventory Outstanding | 562.36 | 657.78 | 342.12 | 293.81 |
| Days of Payables Outstanding | 160.09 | 429.04 | 153.02 | 55.83 |
| Operating Cycle | 618.29 | 709.73 | 395.75 | 617.01 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -10.63 | -0.16 | -0.15 | -0.15 |
| Free Cash Flow Per Share | -10.63 | -0.16 | -0.15 | -0.15 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -1519.14 | -369.76 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -1519.14 | -369.76 |
| Operating Cash Flow Coverage Ratio | -2.25 | -0.57 | -1.13 | -5.47 |
| Operating Cash Flow to Sales Ratio | -3.17 | -2.70 | -2.11 | -2.61 |
| Free Cash Flow Yield | -12.15% | -3.59% | -3.22% | -3.25% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -4.73 | -13.91 | -21.24 | -29.61 |
| Price-to-Sales (P/S) Ratio | 26.11 | 75.32 | 65.58 | 80.41 |
| Price-to-Book (P/B) Ratio | 34.04 | -13.93 | -93.11 | 29.09 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -8.23 | -27.85 | -31.08 | -30.76 |
| Price-to-Operating Cash Flow Ratio | -8.23 | -27.85 | -31.10 | -30.84 |
| Price-to-Earnings Growth (PEG) Ratio | -0.39 | -0.43 | -0.55 | 0.00 |
| Enterprise Value Multiple | -4.85 | -20.14 | -22.90 | -31.35 |
| Enterprise Value | 128.52M | 351.57M | 339.90M | 332.54M |
| EV to EBITDA | -4.85 | -20.14 | -22.90 | -31.35 |
| EV to Sales | 26.02 | 80.07 | 67.40 | 80.85 |
| EV to Free Cash Flow | -8.20 | -29.61 | -31.94 | -30.93 |
| EV to Operating Cash Flow | -8.20 | -29.61 | -31.96 | -31.01 |
| Tangible Book Value Per Share | 1.81 | -0.35 | -0.07 | 0.14 |
| Shareholders’ Equity Per Share | 2.57 | -0.33 | -0.05 | 0.16 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.00 |
| Revenue Per Share | 3.35 | 0.06 | 0.07 | 0.06 |
| Net Income Per Share | -18.32 | -0.29 | -0.22 | -0.15 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.17 | 1.01 | 1.00 |
| Research & Development to Revenue | 0.61 | 0.77 | 0.44 | 0.46 |
| SG&A to Revenue | 2.02 | 2.33 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.15 | 0.20 | 0.03 | 0.04 |
| Income Quality | 0.58 | 0.56 | 0.68 | 0.96 |
Currency in USD

